Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

StemCells (STEM) adds to SC Proven Portfolio

STEM launched 3 new cell culture supplements for the derivation, culture and differentiation of human and mouse embryonic stem (NYSE:ES) cells, induced pluripotent stem (iPS) cells and tissue-derived neural stem (NYSE:NS) cells.

The use of animal component-free formulations is an important consideration for researchers considering bench-to-bedside applications in which human stem cell lines may be derived, expanded and banked for potential future translation into clinical trials.

  • NDiff(NYSE:R) N2-AF is a proprietary, defined, serum-free and animal component-free version of NDiff N2 product, a proprietary, defined, serum-free cell culture supplement based on the original Bottenstein formulation;
  • NDiff N27 is a proprietary, defined, serum-free cell culture supplement based on the original Brewer formulation;
  • NDiff N27-AF is a proprietary, defined, serum-free and animal component-free version of NDiff N27.

The Bottom Line: Expanding lines of SC Proven cell culture supplements provides researchers with well-defined reagents that are free of the serum and animal protein-derived contaminants that can cause variability of performance and impair analyses, particularly in the context of stem cell-based drug screens. These new lines satisfy this demand by providing researchers with additional choices to use either a defined, serum-free, or a defined, serum-free and animal component-free (NYSE:AF) version. The SC Proven product portfolio comprises a range of products for the detection, isolation, expansion, differentiation, and characterization of a variety of different human and animal cell types. In 2010, SC Proven product sales revenue grew by approximately 30%, and continues double digit growth.